Clinical Trial Update: Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fludarabine phosphate and total body irradiation followed by donor peripheral stem cell transplant in myelodysplastic syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Chronic Myeloid Leukemia Bcr-abl1 Negative
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia
• Myeloproliferative Neoplasms

Drugs mentioned

• Donor Peripheral Stem Cell Transplant (peripheral blood stem cell transplant)
• Fludarabine phosphate (Fludarabine phosphate)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-10-24